-
Mashup Score: 1
Background: Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been demonstrated to promote reverse cardiac remodeling in people with diabetes or heart failure. While it has been theorized that
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
Background: Hypertrophic cardiomyopathy (HCM) can be associated with an abnormal exercise response. In adults with HCM, an abnormal exercise stress test is predictive of heart failure outcomes. Our g
Source: CirculationCategories: Cardiac Surgery, Latest HeadlinesTweet
#JustPublished: #AHA22 #CIRCAHA22: Empagliflozin and Left Ventricular Remodeling in People Without Diabetes Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial #AHAJournals https://t.co/AnyS3ITrlX